Access Denied

The ICON team are at AAPS NBC. Stop by booth \#404 to discuss how our comprehensive bioanalytical and early clinical manufacturing solutions can support your research and development goals. https://www.aaps.org/nbc

Menopausal vasomotor symptoms (VMS), including hot flashes and night sweats, are now understood to arise from estrogen‑deficiency–related dysregulation of hypothalamic KNDy neurons, leading to increased neurokinin B (NKB...

We are proud to announce the opening of our new state‑of‑the‑art clinical research unit in San Antonio, Texas, and forthcoming satellite outpatient clinics in Houston, TX and Lawrence, KS. The new CRU integrates clinica...

Cronbach’s alpha has long been the default for COA reliability but is it still fit for purpose? Join Steve Maher, Principal, Patient Centred Outcomes at ICON, for this ISPOR breakout exploring modern approaches to relia...

On 14 May 2026, ICON will host an in person seminar in Shanghai, featuring insights from ICON experts on key topics across biopharmaceutical innovation and development. Taking place from 3:30pm to 6:00pm at the Evergree...

Participant-centric study design has advanced, but site-centric execution has not kept pace. In the Journal for Clinical Studies, Brian Mallon examines how unclear expectations, administrative burden and contract delays ...

As focus on mental health grows, delivering psychedelic therapies requires more than innovation. ICON supported a global programme across 150+ sites in 12 countries, managing complex controlled substance logistics so the...

Oligonucleotide (ON) drug development is accelerating rapidly—but first in human (FIH) studies remain complex. Join our upcoming webinar to explore key translational and clinical considerations for initiating FIH antis...

The ICON Biotech Team is onsite at OCT East Coast in New Brunswick, NJ, today and tomorrow (12-13 May). Meet them at Booth \#25 and explore how we support biotech sponsors with: - End‑to‑end clinical development solutio...

Biotech teams face unique pressures, from rapid decision‑making to scaling programmes without losing momentum. Meet the ICON Biotech team at #ASCO26, booth \#35093 to learn how our biotech‑dedicated specialists combine ...

Starting out in clinical research is about more than gaining experience, it’s about having the right support to grow. In our latest blog, Martina shares how mentorship, collaboration, and hands-on learning helped shape ...

The shift from 100% SDV/SDR is happening at scale. New Tufts CSDD data shows 75% of large sponsors and 51% of small sponsors are already implementing central and risk-based monitoring models. ICON’s own industry research...